Crumly & Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Crumly & Associates's AMGN Position: Q3 2026 in Review
Crumly & Associates reduced its Amgen (AMGN) stake by 21% in Q3 2026, selling an estimated $95.3K and leaving 889 shares worth $375K. The position accounts for 0.07% of the portfolio, ranked #151.
Crumly & Associates first reported a position in AMGN in Q2 2024 and has held it in 10 quarters since. The position peaked at $680K in Q1 2026. 3,271 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Crumly & Associates held 889 shares of Amgen worth $375K as of Q3 2026.
- Crumly & Associates sold 239 Amgen shares in Q3 2026, an estimated $95.3K.
- Amgen made up 0.07% of Crumly & Associates's portfolio in Q3 2026, its #151 holding.
- Crumly & Associates first reported a position in Amgen in Q2 2024 and has held it in 10 quarters since.
- Crumly & Associates's Amgen position peaked at $680K in Q1 2026.
- 3,271 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Crumly & Associates's 13F filing for Q3 2026, filed 7 Oct 2026.